Turning Point Bloodstock – Trademark Portfolio
Entity Type: 16
Turning Point Bloodstock holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DREAMS WORTH RACING FOR. The owner is based in Fort Edward, NY.
106 Reynolds road
Fort Edward, NY 12828
Showing of trademarks Trademarks
Trademark Classifications
Turning Point Bloodstock's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Turning Point Bloodstock have?
Turning Point Bloodstock has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Turning Point Bloodstock file in?
Turning Point Bloodstock files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Turning Point Bloodstock's most well-known trademarks?
Turning Point Bloodstock's registered trademark portfolio includes well-known marks such as DREAMS WORTH RACING FOR. These are among 1 currently registered trademark in the portfolio.
What is Turning Point Bloodstock's trademark registration success rate?
Turning Point Bloodstock has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.